Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Data Component Method Based on Dual-Factor Ownership Identification with Multimodal Feature Fusion. [PDF]
Sensors (Basel)Nie S, Shi J, Zhou X, Lu M.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
A Hybrid Hash-Encryption Scheme for Secure Transmission and Verification of Marine Scientific Research Data. [PDF]
Sensors (Basel)Wang H, Chen M, Wang M, Yang M.
europepmc +1 more source
Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock +4 more
wiley +1 more source
A server-assisted secure blockchain model for residential demand response in smart grids. [PDF]
Sci RepGhosh A +3 more
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
ArtUnmasked: A Multimodal Classifier for Real, AI, and Imitated Artworks. [PDF]
J ImagingChidrawar A, Bajwa G.
europepmc +1 more source
A secure multi phase authentication protocol for cloud infrastructure using elliptic curve cryptography. [PDF]
Sci RepSivasankar R, Marikkannan M.
europepmc +1 more source
A Post-Quantum Secure RFID Authentication Protocol Based on NTRU Encryption Algorithm. [PDF]
Sensors (Basel)Liu H, Wu H, Ge N, Dong Q.
europepmc +1 more source